Daniel Gallares
Internal Medicine · Hilo, HINPI 1245689488
Payments from drug & device makers
Across 165 payments — averaging $33.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$813
- Gilead$579
- Amgen$465
- Lilly USA, LLC$417
- Boehringer Ingelheim$371
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,454100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $1,081 |
| AstraZeneca | 30 | $813 |
| Gilead | 5 | $579 |
| Amgen(2 entities) | 12 | $465 |
| Lilly USA, LLC | 17 | $417 |
| Boehringer Ingelheim | 14 | $371 |
| Sanofi-aventis U.S. LLC | 8 | $359 |
| Pfizer | 4 | $279 |
| Johnson & Johnson | 7 | $266 |
| Amarin Pharma, Inc. | 6 | $148 |
| Novo Nordisk | 8 | $135 |
| Viiv Healthcare Company | 1 | $106 |
| GSK | 3 | $82 |
| Arbor Pharmaceuticals, Inc. | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Ironwood Pharmaceuticals, Inc | 3 | $47 |
| Vifor Pharma, Inc. | 2 | $44 |
| Insmed, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Merck | 1 | $20 |
| Radius Health, Inc. | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,469 in reported general payments places this provider in the 85th percentile of 655 internal medicine providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 26 | $30,477 |
| EliquisApixaban | 17 | $29,055 |
| JardianceEmpagliflozin | 20 | $26,238 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $16,304 |
| FarxigaDapagliflozin Propanediol | 11 | $8,732 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,702 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,621 |
| Atorvastatin Calcium | 198 | $1,481 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 16 | $875 |
| Rosuvastatin Calcium | 27 | $763 |
| Tamsulosin Hcl | 60 | $748 |
| Gabapentin | 38 | $672 |
| Losartan Potassium | 86 | $593 |
| Lisinopril | 116 | $563 |
| Amlodipine Besylate | 144 | $556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $417 | $30,47726 claims |
| PfizerEliquis | $279 | $29,05517 claims |
| Boehringer IngelheimJardiance | $371 | $26,23820 claims |
| AstraZenecaFarxiga | $813 | $8,73211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 655 internal medicine providers in Hawaii.
Other internal medicine in Hilo
- Michael SavonaWailuku$520K
- Scott StromattKamuela$385K
- Keith WooHonolulu$106K
- Ronald PerryHonolulu$102K
- Laurie TomHonolulu$95K
- Yusuke MiyataniHonolulu$80K
- Joshua TanHonolulu$76K
- Jose de LeonHonolulu$52K
- Peter DeeHonolulu$49K
- James LumengHonolulu$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.